[Experimentally induced diabetic retinal microangiopathy and polyol pathway. II. Effect of aldose reductase inhibitors on microangiopathy].
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D003930:Diabetic Retinopathy / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*; D013844:Thiazoles / Q000627:therapeutic use*; D053778:Thiazolidines
D013844:Thiazoles; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase